Technical Analysis for DAWN - Day One Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 16.62 5.43% 0.86
DAWN closed up 2.14 percent on Thursday, November 7, 2024, on 1.27 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 5.43%
Calm After Storm Range Contraction 5.43%
NR7 Range Contraction 5.43%
Upper Bollinger Band Walk Strength 5.43%
Above Upper BB Strength 5.43%
Up 3 Days in a Row Strength 5.43%
Up 4 Days in a Row Strength 5.43%
Upper Bollinger Band Touch Strength 5.43%
Pocket Pivot Bullish Swing Setup 7.68%
Calm After Storm Range Contraction 7.68%

   Recent Intraday Alerts

Alert Time
Possible Pocket Pivot about 3 hours ago
Up 5% about 5 hours ago
Up 1 ATR about 5 hours ago
60 Minute Opening Range Breakout about 6 hours ago
Rose Above Previous Day's High about 6 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Enzymes Signal Transduction Protein Kinase Inhibitor Protein Kinase Kinase

Is DAWN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.0699
52 Week Low 10.9
Average Volume 1,048,078
200-Day Moving Average 14.64
50-Day Moving Average 14.29
20-Day Moving Average 14.74
10-Day Moving Average 14.84
Average True Range 0.74
RSI (14) 68.35
ADX 30.66
+DI 30.37
-DI 9.17
Chandelier Exit (Long, 3 ATRs) 14.02
Chandelier Exit (Short, 3 ATRs) 15.63
Upper Bollinger Bands 15.58
Lower Bollinger Band 13.89
Percent B (%b) 1.11
BandWidth 11.47
MACD Line 0.29
MACD Signal Line 0.18
MACD Histogram 0.1013
Fundamentals Value
Market Cap 1.37 Billion
Num Shares 87 Million
EPS -2.29
Price-to-Earnings (P/E) Ratio -6.88
Price-to-Sales 0.00
Price-to-Book 3.40
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.78
Resistance 3 (R3) 16.79 16.47 16.61
Resistance 2 (R2) 16.47 16.21 16.46 16.55
Resistance 1 (R1) 16.11 16.05 16.29 16.10 16.50
Pivot Point 15.79 15.79 15.88 15.78 15.79
Support 1 (S1) 15.43 15.53 15.61 15.42 15.02
Support 2 (S2) 15.11 15.37 15.10 14.97
Support 3 (S3) 14.75 15.11 14.91
Support 4 (S4) 14.74